A new dedicated service for CAR T-cell therapy is set to launch, aimed at improving treatment options for patients with blood cancers. This innovative...
A new dedicated CAR T-cell therapy service will be established to enhance treatment options for patients suffering from blood cancers. This innovative therapy, which...
T-CURX GmbH, a biotechnology start-up based in Würzburg, has successfully secured $20 million in its initial financing round. This investment, led by the Swiss...